High-dose methotrexate for the treatment of primary cerebral lymphomas: Analysis of survival and late neurologic toxicity in a retrospective series

Journal of Clinical Oncology

Volumn 16, Issue 3, 1998, Pages 864-871

  Blay, Jean Yves ^a   Conroy, Thierry ^a   Chevreau, Christine ^a   Thyss, Antoine ^a   Quesnel, Nathalie ^a   Eghbali, Houchingue ^a   Bouabdallah, Reda ^a   Coiffier, Bertrand ^a   Wagner, Jean Philippe ^a   Le Mevel, Annick ^a   Dramais Marcel, Dominique ^a   Baumelou, Elisabeth ^a   Chauvin, Frank ^a   Biron, Pierre ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; LOMUSTINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINDESINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CANCER RADIOTHERAPY; CANCER SURVIVAL; DOSE RESPONSE; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

EID: 0031887536     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.3.864     Document Type: Article

References (25)

1. Henry JM, Heffner RR Jr, Dillard SH, et al: Primary malignant lymphoma of the central nervous system. Cancer 34:1293-1302, 1974
2. Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system: Results of the treatment of 11 cases and review of the literature. J Neurosurg 65:600-607, 1986
3. Hochberg FH, Miller DC: Primary central nervous system lymphoma. J Neurosurg 68:835-853, 1988
4. Fine HA, Mayer RJ: Primary central nervous system lymphoma. Ann Int Med 119:1093-1104, 1993
5. De Angelis L: Primary central nervous system lymphoma, in Educational Book of the 30th Annual Meeting of the American Society of Clinical Oncology, Dallas, TX, May 14-17, 1994, pp 236-239
6. Eby NL, Grufferman S, Flannelly CM, et al: Increasing incidence of primary cerebral lymphoma in the US. Cancer 62:2461-2465, 1988
7. Ahsan H, Neugut AI, Bruce JW: Trends in incidence of primary brain tumors in USA 1981-1990. Int J Epidemiol 24:1078-1085, 1995
8. Ervin T, Canellos G: Successful treatment of recurrent primary cerebral lymphoma with high-dose methotrexate. Cancer 45:1556-1557, 1980
9. Neuwelt EA, Goldman DL, Dahlborg SA, et al: Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitive function. J Clin Oncol 9:1580-1590, 1991
10. Loeffler JS, Ervin TJ, Mauch P, et al: Primary lymphomas of the central nervous system: Patterns of failure and factors that influence survival. J Clin Oncol 3:490-494, 1985
11. Cohen IJ, Vogel R, Matz S, et al: Successful nonneurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine and BCNU protocol (DEMOB). Cancer 57:6-11, 1986
12. Shibamato Y, Tsutsui K, Dodo Y, et al: Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer 65:1907-1912, 1990
13. Glass J, Gruber ML, Cher L, et al: Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome. J Neurosurg 81:188-195, 1994
14. Brada M, Dearnaley D, Horwich A, et al: Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 18:787-792, 1990
15. De Angelis L, Yahalom J, Thaler HT, et al: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10:635-643, 1992
16. Lachance DH, Gockerman J, Halperin E, et al: CHOP for primary central nervous system lymphoma: Short duration response, multifocal intracerebral recurrence preceding radiotherapy. Neurology 42:343-349, 1992 (suppl 3)
17. Blay J-Y, Bouhour D, Carrie C, et al: The C5R protocol: A regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression. Blood 86:2922-2929, 1995
18. Schultz C, Scott C, Sherman W, et al: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: Initial report of Radiation Therapy Oncology Group protocol 88-06. J Clin Oncol 14:556-564, 1996
19. Haioun C, Lepage E, Gisselbrecht C, et al, for the GELA: Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: A study of 464 patients. J Clin Oncol 12:2543-2551, 1994
20. Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
21. Kaplan EL, Meier P: Nonparametric estimations from incomplete observations. J Am Stat Assoc 53:457-481, 1958
22. Cox DR: Regression model and life table. J R Stat Soc 34:187-220, 1972
23. The International Non-Hodgkin's Lymphoma Prognostic Factor Project: A predictive model for aggressive primary non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
24. Blay JY, Lasset C, Carrie C, et al: Multivariate analysis of prognostic factors in patients with non - HIV-related primary cerebral lymphoma: A proposal for a prognostic scoring. Br J Cancer 67:1136-1141, 1993
25. Bleyer WA: Neurologic sequelae of methotrexate and ionizing radiation: A new classification. Cancer Treat Rep 65:89-98, 1981 (suppl 1)